This federal contract award, valued at $16,095.56, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of December 20, 2024.
The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has significant experience providing a wide range of pharmaceutical products and medical supplies to federal government agencies, particularly the DLA and Department of Justice. This contract is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing essential medical commodities to support military healthcare programs globally.
Generated 3/20/25, 9:59 AM